BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1680 related articles for article (PubMed ID: 15135458)

  • 21. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
    Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
    Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of acute normovolemic hemodilution in patients undergoing radical prostatectomy.
    Terai A; Terada N; Yoshimura K; Ichioka K; Ueda N; Utsunomiya N; Kohei N; Arai Y; Yonei A
    Urology; 2005 Jun; 65(6):1152-6. PubMed ID: 15913718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood management in intensive care medicine: CRIT and ABC--what can we learn?
    Spahn DR; Marcucci C
    Crit Care; 2004 Apr; 8(2):89-90. PubMed ID: 15025763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study.
    Zilberberg MD; Carter C; Lefebvre P; Raut M; Vekeman F; Duh MS; Shorr AF
    Crit Care; 2007; 11(3):R63. PubMed ID: 17553147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
    Chun TY; Martin S; Lepor H
    Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anemia in critically ill patients.
    van de Wiel A
    Eur J Intern Med; 2004 Dec; 15(8):481-486. PubMed ID: 15668082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of epoetin alfa in critically ill patients.
    Pajoumand M; Erstad BL; Camamo JM
    Ann Pharmacother; 2004 Apr; 38(4):641-8. PubMed ID: 14966258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery.
    Habler O; Schwenzer K; Zimmer K; Prager M; König U; Oppenrieder K; Pape A; Steinkraus E; Reither A; Buchrot A; Zwissler B
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):467-75. PubMed ID: 15183411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia and blood transfusion in the critically ill patient: role of erythropoietin.
    Corwin HL
    Crit Care; 2004; 8 Suppl 2(Suppl 2):S42-4. PubMed ID: 15196323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical consequences of anemia and red cell transfusion in the critically ill.
    Hébert PC; McDonald BJ; Tinmouth A
    Crit Care Clin; 2004 Apr; 20(2):225-35. PubMed ID: 15135462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?
    Walsh TS; McArdle F; McLellan SA; Maciver C; Maginnis M; Prescott RJ; McClelland DB
    Crit Care Med; 2004 Feb; 32(2):364-71. PubMed ID: 14758149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy.
    MacIvor D; Nelson J; Triulzi D
    Transfusion; 2009 Jul; 49(7):1431-4. PubMed ID: 19320863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery.
    Braga M; Gianotti L; Gentilini O; Vignali A; Di Carlo V
    Hepatogastroenterology; 1997; 44(15):685-90. PubMed ID: 9222672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
    Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
    JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anemic patient in the ICU: How much does the heart tolerate?
    Hérbert PC; Szick S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S94-100. PubMed ID: 11753708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy.
    Park J; Gage BF; Vijayan A
    Am J Kidney Dis; 2005 Nov; 46(5):791-8. PubMed ID: 16253718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.
    Jarnagin WR; Gonen M; Maithel SK; Fong Y; D'Angelica MI; Dematteo RP; Grant F; Wuest D; Kundu K; Blumgart LH; Fischer M
    Ann Surg; 2008 Sep; 248(3):360-9. PubMed ID: 18791356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma.
    Kettelhack C; Hönes C; Messinger D; Schlag PM
    Br J Surg; 1998 Jan; 85(1):63-7. PubMed ID: 9462386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion strategies for patients in pediatric intensive care units.
    Lacroix J; Hébert PC; Hutchison JS; Hume HA; Tucci M; Ducruet T; Gauvin F; Collet JP; Toledano BJ; Robillard P; Joffe A; Biarent D; Meert K; Peters MJ; ; ;
    N Engl J Med; 2007 Apr; 356(16):1609-19. PubMed ID: 17442904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.